Why the study?
While cryoballoon ablation is established for paroxysmal AF, its role in persistent AF remains unclear.
Does cryoballoon ablation reduce the recurrence of atrial tachyarrhythmias in patients with symptomatic paroxysmal and persistent atrial fibrillation compared to radiofrequency catheter ablation?
Comparison
Cryoballoon ablation vs radiofrequency catheter ablation
Design
Retrospective study
Follow-up
12 months
Key result
Cryoballoon ablation showed comparable 12-month atrial tachyarrhythmia-free survival compared to radiofrequency catheter ablation in the overall cohort (72.7% vs 80.6%; HR 1.36, p=0.123).
Authors
Loading...
Either technique remains a reasonable option in current practice; leaves open confirmation of equivalence in prospective studies.
Cohort (n=410)
No
Does cryoballoon ablation reduce the recurrence of atrial tachyarrhythmias in patients with symptomatic paroxysmal and persistent atrial fibrillation compared to radiofrequency catheter ablation?
Hazard Ratio: 1.36 (95% CI 0.91–2.04)
Absolute Event Rate: 72.7% vs 80.6%
p-value: p=0.123
Cryoballoon ablation offers comparable efficacy to radiofrequency catheter ablation for paroxysmal atrial fibrillation but is less effective for maintaining sinus rhythm in persistent atrial fibrillation.
Choi et al. (2022) conducted a cohort in Symptomatic paroxysmal and persistent atrial fibrillation (n=410). Cryoballoon ablation vs. Radiofrequency catheter ablation (RFCA) was evaluated on Freedom from any atrial tachyarrhythmias (ATas) at 12 months (HR 1.36, 95% CI 0.91-2.04, p=0.123). Cryoballoon ablation showed comparable 12-month atrial tachyarrhythmia-free survival compared to radiofrequency catheter ablation in the overall cohort (72.7% vs 80.6%; HR 1.36, p=0.123).